ShockWave Medical, Inc. (SWAV) Financial Metrics
This dashboard provides comprehensive financial metrics and analysis to help evaluate ShockWave Medical, Inc.'s investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.
Financial Metrics Score
Valuation Metrics
Sector benchmarks: Industrials
P/E Ratio
47.52
Weak
WeakModerateStrong
P/B Ratio
10.46
Weak
WeakModerateStrong
Earnings Yield
2.11%
Yield Trap
WeakModerateStrong
Profitability Health
2023Return on Equity
22.03%
Strong
WeakModerateStrong
Operating Margin
22.73%
Strong
WeakModerateStrong
Net Profit Margin
20.17%
Strong
WeakModerateStrong
Growth Indicators
2023Revenue Growth
49.11%
Strong
WeakModerateStrong
Net Income Growth
-31.81%
Weak
WeakModerateStrong
EPS Growth
-33.39%
Weak
WeakModerateStrong
Efficiency & Liquidity
2023Current Ratio
11.76
Strong
WeakModerateStrong
Quick Ratio
10.73
Strong
WeakModerateStrong
Asset Turnover
0.47x
Weak
WeakModerateStrong
Inventory Turnover
0.89x
Weak
WeakModerateStrong
Cash Flow & Resilience
Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes
Free Cash Flow Yield
2.37%
Weak
WeakModerateStrong
EV / Free Cash Flow
44.95x
Weak
WeakModerateStrong
Net Debt / EBITDA
2.32x
Weak
WeakModerateStrong
Interest Burden (EBT / EBIT)
1.050
Strong
WeakModerateStrong
Return on Invested Capital
9.57%
Weak
WeakModerateStrong
Cash Conversion Cycle
435.00 days
Weak
WeakModerateStrong
Fortress screener guardrails
0/4 passing
- FCF Yield > 3%
- Net Debt / EBITDA < 1.5x
- ROIC > 20%
- Cash Conversion Cycle < 0 days
Financial Statements
Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for SWAV.
View Financial Statements